Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty - The REMEDY Study

NCT02205775 is registered in ClinicalTrials.gov with G. d'Annunzio University as lead sponsor.

NCT NCT02205775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02205775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty - The REMEDY Study
Lead sponsor
G. d'Annunzio University
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2010
Completion date
June 30, 2012
Enrollment
280 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

stable coronary artery disease undergoing pci